01.
CHITOGEN™
MEDIFAB's proprietary ingredient made by solubilizing insoluble chitosan and applying LTG (Liquid-to-Gel) technology to create an anti-inflammatory, antioxidant, and skin-recovery environment.
R&D
Three Platforms,
One Molecular Foundation
Chitosan-based molecular engineering powers three distinct technology platforms — each validated through clinical evidence and global regulatory approval.
View All R&D
01.
02.
REGENTRIX™
A proprietary MEDIFAB platform that implements regenerative signals, manufactured as a dECM (Decellularized Extracellular Matrix) material by decellularizing xenogeneic dermal tissue through a supercritical CO₂ process.
03.
CHITOGENIX™
A hybrid biomaterial that combines Chitogen™ — water-solubilized chitosan processed with LTG — and Regentrix™, a dECM-based platform. Designed so cells can recover on their own by shaping both conditions and signals together.
PRODUCTS
Solutions from
Clinic to Home
MEDIFAB provides comprehensive anti-aging solutions spanning professional medical aesthetics to everyday home care.
Skin boosters built on Medifab's proprietary platforms — Chitogen™, Regentrix™, and Chitogenix™. Combining the biocompatibility of chitosan-derived materials with regenerative technology, they work with the skin's own capacity to recover.
A lineup of medical devices including bioresorbable implants and HA fillers. Built on materials engineered to break down safely in the body, they support clinical environments that account for the full course of recovery.
res novae is a high-performance dermocosmetic brand spanning skin and scalp care. It brings Medifab's research into everyday routines, helping support balance in sensitized skin and scalp.
MEDINOVAE is a professional-use brand built on cell-boosting technology. Its formulations are designed to work at the cellular level and to integrate reliably into treatment protocols.
An ODM business built on MEDIFAB's proprietary ingredients. We handle the full process — ingredient development, formulation design, and production — working with partners to bring products to market that match their brand.
MEDIA
News & Publications
View All MediaMedifab participates in ‘Dubai Derma 2026’… Targeting the Middle East premium aesthetic market
Global medical aesthetics company Medifab participated in ‘Dubai Derma 2026’ to showcase its water-soluble chitosan-based skin booster technology and strengthen its penetration into the Middle East market. Medifab participated with a solo booth at Dubai Derma 2026, held in Dubai from the 8th to the 10th (local time), targeting local medical professionals, buyers, and industry stakeholders with its...
See ArticleCha Mi-sun, CEO of Medipab: A first mover leading anti-aging innovation through regenerative medicine
“We don't just create fillers, we create regeneration.” As the axis of the anti-aging industry shifts from ‘beauty‘ to “regeneration,” Medifab, a specialized bio-regenerative medicine company, is growing its presence right at the center of that change. Based on its chitosan and decellularized extracellular matrix (dECM)-based regeneration platforms, Medifab has expanded its business areas beyond skin care to hair loss and joint regeneration, proving its growth potential by securing 29 billion won in investment, and...
See ArticleKorean Academy of Aesthetic Obesity and Regenerative Medicine Live Academy successfully concludes… introducing how to use chitosan skin boosters
The Korean Academy of Obesity, Aesthetics and Regenerative Medicine (hereafter KORA) announced that it successfully concluded the ‘2026 KORA 2nd Live Academy' held on August 30 at the Auditorium of Konkuk University Medical Center. (Top) The Medifab booth operated during the 2026 KORA Live Academy, (Bottom) Director Kim Si-yeon of the Parkview Clinic Cheongna branch conducting a live demonstration using Resnove Crystal Plus. On this day...
See ArticleCONTACT
Leave your inquiry about distribution partnerships, product import/export, or ODM collaboration.
Korean 
English 
Japanese 
Chinese